Is Prozac (fluoxetine) effective for treating binge eating disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Prozac (Fluoxetine) Effective for Binge Eating Disorder?

Prozac (fluoxetine) is NOT recommended as a primary treatment for binge eating disorder, as it has not demonstrated superiority over placebo in reducing binge eating episodes and is not FDA-approved for this indication. 1, 2

FDA Approval Status and Evidence

  • Fluoxetine is FDA-approved for bulimia nervosa (at 60 mg/day) but is not approved for binge eating disorder 1
  • The FDA label for fluoxetine specifically indicates efficacy for "binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa" but makes no mention of binge eating disorder as an indication 1

Direct Evidence Against Fluoxetine for BED

  • In a high-quality randomized controlled trial, fluoxetine 60 mg/day showed no superiority over placebo for binge eating disorder, with remission rates of only 22% (fluoxetine) versus 26% (placebo) in intent-to-treat analysis 2
  • Fluoxetine alone failed to demonstrate efficacy for behavioral and psychological features of BED, though it is effective for bulimia nervosa 2
  • When combined with cognitive behavioral therapy (CBT), adding fluoxetine provided no clear advantage over CBT alone 3

Recommended Treatment Approach

First-line treatment for BED should be psychotherapy, specifically cognitive-behavioral therapy (CBT) or interpersonal therapy 4, 5

When to Consider Medication

Medications should be considered when: 4, 5

  • Patients prefer medication over psychotherapy
  • Patients have not responded adequately to psychotherapy alone
  • Comorbid obesity is present

FDA-Approved Medication Option

  • Lisdexamfetamine is the only FDA-approved medication specifically for moderate-to-severe binge eating disorder and should be the first-line pharmacological choice when medication is indicated 6, 4

Alternative Medication Options (Off-Label)

If lisdexamfetamine is not appropriate, consider: 4, 5

  • Topiramate - has substantial evidence for reducing binge eating behaviors
  • Naltrexone/Bupropion - particularly useful for patients with food cravings or addictive eating patterns, or comorbid depression

Important Clinical Caveat

  • While fluoxetine has modest short-term effects in some older studies showing reduction in binge frequency 7, 8, the most rigorous head-to-head comparison demonstrated it was not superior to placebo 2
  • Avoid weight gain-inducing medications such as mirtazapine and tricyclic antidepressants in BED patients with obesity 4, 5

Key Distinction: BED vs. Bulimia Nervosa

  • Fluoxetine 60 mg/day is effective and FDA-approved for bulimia nervosa (which includes compensatory purging behaviors) 1, 9, 8
  • Binge eating disorder differs from bulimia nervosa by the absence of compensatory behaviors and requires different pharmacological management 10

References

Guideline

Medications for Binge Eating Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medications for Binge Eating Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Binge Eating Disorder Treatment with Lisdexamfetamine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.

The British journal of psychiatry : the journal of mental science, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.